EARN25

Technical Trouble Haunts This Medtech Name

The equity is coming off a brief rally

Digital Content Manager
Oct 6, 2022 at 12:20 PM
facebook X logo linkedin


The shares of Illumina, Inc. (NASDAQ:ILMN) got a kick from this week's broad-market rally, surging 9.5% on Tuesday to mark its biggest one-day jump since January. The stock looks to be erasing some of these gains during today's trading, last seen down 2.5% at $212.91, and things could get even worse for the medtech concern, as this week's positive price action put the security back near a historically bearish trendline. 

The trendline in question, ILMN's 120-day moving average, has only been toppled twice on a daily closing basis since September 2021. Looking back three years, there have been five other instances when the stock came within one standard deviation of this trendline, according to data from Schaeffer's Senior Quantitative Analyst Rocky White. One month later, the shares were negative 60% of the time -- including the two most recent -- averaging a 2.5% drop. A similar move from its current perch could put the security back near the $207 mark. 

ilmn oct 6

Analysts, meanwhile, are split on the equity. Of the 11 in coverage, five say "strong buy," and six say "hold" or worse. On the other hand, short interest is starting to rise, up 24.8% in the last two reporting periods, though the 4.37 million shares sold short make up a just 2.8% of the stock's available float. 

Options traders have been incredibly bullish, though. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), ILMN sports a 50-day put/call volume ratio of 3.88, which stands higher than 80% of readings from the past year. In other words, options players are pricing in relatively low volatility expectations at the moment. 

 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!